<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tarini BA</submitter><funding>NICHD NIH HHS</funding><pagination>446-61</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3288389</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>47(1 Pt 2)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To estimate the impact of the mandatory National Collegiate Athletic Association (NCAA) sickle cell trait (SCT) screening policy on the identification of sickle cell carriers and prevention of sudden death.&lt;h4>Data source&lt;/h4>We used NCAA reports, population-based SCT prevalence estimates, and published risks for exercise-related sudden death attributable to SCT.&lt;h4>Study design&lt;/h4>We estimated the number of sickle cell carriers identified and the number of potentially preventable sudden deaths with mandatory SCT screening of NCAA Division I athletes. We calculated the number of student-athletes with SCT using a conditional probability based upon SCT prevalence data and self-identified race/ethnicity status. We estimated sudden deaths over 10 years based on published attributable risk of exercise-related sudden death due to SCT.&lt;h4>Principal findings&lt;/h4>We estimate that over 2,000 NCAA Division I student-athletes with SCT will be identified under this screening policy and that, without intervention, about seven NCAA Division I student-athletes would die suddenly as a complication of SCT over a 10-year period.&lt;h4>Conclusion&lt;/h4>Universal sickle cell screening of NCAA Division I student-athletes will identify a substantial number of sickle cell carriers. A successful intervention could prevent about seven deaths over a decade.</pubmed_abstract><journal>Health services research</journal><pubmed_title>A policy impact analysis of the mandatory NCAA sickle cell trait screening program.</pubmed_title><pmcid>PMC3288389</pmcid><funding_grant_id>K12 HD055894</funding_grant_id><funding_grant_id>K23 HD057994-03</funding_grant_id><funding_grant_id>K23 HD057994</funding_grant_id><funding_grant_id>K23HD057994</funding_grant_id><pubmed_authors>Tarini BA</pubmed_authors><pubmed_authors>Bundy DG</pubmed_authors><pubmed_authors>Brooks MA</pubmed_authors></additional><is_claimable>false</is_claimable><name>A policy impact analysis of the mandatory NCAA sickle cell trait screening program.</name><description>&lt;h4>Objective&lt;/h4>To estimate the impact of the mandatory National Collegiate Athletic Association (NCAA) sickle cell trait (SCT) screening policy on the identification of sickle cell carriers and prevention of sudden death.&lt;h4>Data source&lt;/h4>We used NCAA reports, population-based SCT prevalence estimates, and published risks for exercise-related sudden death attributable to SCT.&lt;h4>Study design&lt;/h4>We estimated the number of sickle cell carriers identified and the number of potentially preventable sudden deaths with mandatory SCT screening of NCAA Division I athletes. We calculated the number of student-athletes with SCT using a conditional probability based upon SCT prevalence data and self-identified race/ethnicity status. We estimated sudden deaths over 10 years based on published attributable risk of exercise-related sudden death due to SCT.&lt;h4>Principal findings&lt;/h4>We estimate that over 2,000 NCAA Division I student-athletes with SCT will be identified under this screening policy and that, without intervention, about seven NCAA Division I student-athletes would die suddenly as a complication of SCT over a 10-year period.&lt;h4>Conclusion&lt;/h4>Universal sickle cell screening of NCAA Division I student-athletes will identify a substantial number of sickle cell carriers. A successful intervention could prevent about seven deaths over a decade.</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Feb</publication><modification>2024-11-08T17:21:00.449Z</modification><creation>2019-03-27T00:49:31Z</creation></dates><accession>S-EPMC3288389</accession><cross_references><pubmed>22150647</pubmed><doi>10.1111/j.1475-6773.2011.01357.x</doi></cross_references></HashMap>